Inhibitors Targeting CDK9 Show High Efficacy against Osimertinib and AMG510 Resistant Lung Adenocarcinoma Cells

SIMPLE SUMMARY: Non-small cell lung cancer accounts for 80% of all lung cancer cases. While a subset of non-small cell lung cancer patients respond to immunotherapy, those who are treated with chemotherapy or targeted therapy develop resistance to the drugs. Thus, novel therapeutic strategies are ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Padmanabhan, Jaya, Saha, Biswarup, Powell, Chase, Mo, Qianxing, Perez, Bradford A., Chellappan, Srikumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345430/
https://www.ncbi.nlm.nih.gov/pubmed/34359807
http://dx.doi.org/10.3390/cancers13153906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345430/
https://www.ncbi.nlm.nih.gov/pubmed/34359807
http://dx.doi.org/10.3390/cancers13153906

Ejemplares similares